Andrew Cheng, President and CEO at Akero Therapeutics, Inc. (AKRO), sold 1,738 shares at $26.18 ($46K) on 2024-09-10, disclosed to the SEC on 2024-09-13.
Seasonal sale ($46k) by President and CEO — this insider has traded AKRO in September in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| AKRO | SELL | 2025-08-13 | $2.9M | — | Filing → |
| AKRO | SELL | 2025-07-11 | $3.1M | — | Filing → |
| AKRO | SELL | 2025-06-20 | $726K | — | Filing → |